Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

January 11, 2017 updated by: New York University

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy

The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment

585

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Los Angeles, California, United States, 90016
        • Matrix Institute on Addictions
      • Tarzana, California, United States, 91356
        • Tarzana Treatment Center
    • Florida
      • Miami, Florida, United States, 33156
        • Spectrum
      • Orlando, Florida, United States, 32805
        • Center for Drug Free Living
    • Michigan
      • Ann Arbor, Michigan, United States, 48103
        • Chelsea Arbor Addictions Treatment Center
      • Detroit, Michigan, United States, 48207
        • Psychiatry and Behavioral Medicine Professionals I
    • New York
      • Long Island City, New York, United States, 11101
        • Narco Freedom (Bridge Plaza)
      • New York, New York, United States, 10029
        • Mount Sinai Medical Center
      • New York, New York, United States, 10019
        • St. Luke's Roosevelt Hospital Center
      • New York, New York, United States, 10025
        • St. Luke's Roosevelt Hospital Center, Womens
    • North Carolina
      • Concord, North Carolina, United States, 28001
        • Piedmont Behavioral Healthcare
      • Wilmington, North Carolina, United States, 28412
        • Coastal Horizons Center, Inc.
    • South Carolina
      • Pickens, South Carolina, United States, 29671
        • Behavioral Health Services of Pickens County

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient is alcohol or drug dependent, in Outpatient Drug-Free or Opiate Substitute program and is interested in quitting smoking

Exclusion Criteria:

  • Patient is psychotic
  • Use of smokeless tobacco
  • Use of other smoking cessasation product
  • Pregnancy
  • Patient has hyper-tension, heart problems, or skin condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Drug use
Smoking Cessation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

New York University

Investigators

  • Principal Investigator: Malcolm Reid, Ph.D., New York University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2003

Primary Completion (Actual)

July 1, 2004

Study Completion (Actual)

July 1, 2004

Study Registration Dates

First Submitted

August 12, 2003

First Submitted That Met QC Criteria

August 12, 2003

First Posted (Estimate)

August 13, 2003

Study Record Updates

Last Update Posted (Estimate)

January 12, 2017

Last Update Submitted That Met QC Criteria

January 11, 2017

Last Verified

April 1, 2010

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIDA-CTN-0009-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe